Kirchmaier CM - Search Results

1

Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin.

Harenberg J, Huisman MV, Tolle AR, Breddin HK, Kirchmaier CM. Harenberg J, et al. Among authors: kirchmaier cm. Semin Thromb Hemost. 2001 Oct;27(5):513-8. doi: 10.1055/s-2001-17953. Semin Thromb Hemost. 2001. PMID: 11668421 Clinical Trial.

2

Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosis.

Kaiser B, Kirchmaier CM, Breddin HK, Fu K, Fareed J. Kaiser B, et al. Among authors: kirchmaier cm. Semin Thromb Hemost. 1999;25 Suppl 3:35-42. Semin Thromb Hemost. 1999. PMID: 10549714 Review.

3

Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin--results of a pilot study.

Kirchmaier CM, Lindhoff-Last E, Rübesam D, Scharrer I, Vigh Z, Mosch G, Wolf H, Breddin HK. Kirchmaier CM, et al. Thromb Res. 1994 Mar 1;73(5):337-48. doi: 10.1016/0049-3848(94)90029-9. Thromb Res. 1994. PMID: 8016818 Clinical Trial.

4

Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.

Kirchmaier CM, Wolf H, Schäfer H, Ehlers B, Breddin HK. Kirchmaier CM, et al. Int Angiol. 1998 Sep;17(3):135-45. Int Angiol. 1998. PMID: 9821025 Clinical Trial.

5

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects.

Klinkhardt U, Graff J, Westrup D, Kirchmaier CM, Esslinger HU, Breddin HK, Harder S. Klinkhardt U, et al. Among authors: kirchmaier cm. Br J Clin Pharmacol. 2001 Sep;52(3):297-305. doi: 10.1046/j.0306-5251.2001.01446.x. Br J Clin Pharmacol. 2001. PMID: 11560562 Free PMC article. Clinical Trial.

6

Changes of spontaneous and induced platelet aggregation in the presence of a human endothelial cell monolayer.

Altorjay I, Kirchmaier CM, Breddin HK. Altorjay I, et al. Among authors: kirchmaier cm. Thromb Res. 1989 Jul 1;55(1):69-77. doi: 10.1016/0049-3848(89)90457-x. Thromb Res. 1989. PMID: 2781521

7

Substitution of antithrombin III.

Breddin HK, Kirchmaier CM. Breddin HK, et al. Among authors: kirchmaier cm. Wien Klin Wochenschr. 1984 Dec 21;96(24):875-9. Wien Klin Wochenschr. 1984. PMID: 6528616

8

[Effect of subcutaneous administration of lactobionic acid on coagulation and platelet function].

Kirchmaier CM, Lindhoff E, Basic-Micic M, Breddin HK. Kirchmaier CM, et al. Vasa Suppl. 1991;33:168. Vasa Suppl. 1991. PMID: 1788660 German. No abstract available.

9

Functional studies on platelets of a patient with an acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIB/IIIA complex.

Spangenberg P, Kirchmaier CM, Schirmer A, Meyer M, Breddin HK. Spangenberg P, et al. Among authors: kirchmaier cm. Thromb Res. 1993 Mar 1;69(5):435-42. doi: 10.1016/0049-3848(93)90232-d. Thromb Res. 1993. PMID: 8497859

10

In vitro dose response to different GPIIb/IIIa-antagonists: inter-laboratory comparison of various platelet function tests.

Harder S, Klinkhardt U, Graff J, Westrup D, Kirchmaier CM, Glusa E, Mascelli MA, Marciniak SJ, Just A, Lösche W, Breddin HK. Harder S, et al. Among authors: kirchmaier cm. Thromb Res. 2001 Apr 1;102(1):39-48. doi: 10.1016/s0049-3848(01)00223-7. Thromb Res. 2001. PMID: 11323013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters